Trials / Completed
CompletedNCT01925222
Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage: a FinIP Effectiveness Trial Satellite Study During PCV National Vaccination Programme
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,900 (actual)
- Sponsor
- Arto Palmu · Other Government
- Sex
- All
- Age
- 3 Years – 9 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the direct effects of the ten-valent pneumococcal conjugate vaccine administered to infants on nasopharyngeal carriage at 3 to 5 years of age. These children have been vaccinated in infancy in the cluster-randomized Finnish Invasive pneumococcal Disease (FinIP) Trial (a separate protocol reported at ClinicalTrials.gov Identifier:NCT00861380) during 2009 to 2011. Also the indirect effect on nasopharyngeal carriage will be assessed on vaccinees' elder non-vaccinated siblings aged 5 to 9 years.
Detailed description
This study includes a cross-sectional sampling of nasopharyngeal and oropharyngeal swabs in 2013 from vaccinated and unvaccinated children.
Conditions
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2013-08-19
- Last updated
- 2017-03-30
Locations
1 site across 1 country: Finland
Source: ClinicalTrials.gov record NCT01925222. Inclusion in this directory is not an endorsement.